Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary Fibrosis
Description
There have been significant collaborative efforts over the past three years to develop therapies against COVID-19. During this journey, there has also been a lot of focus on understanding at-risk groups of patients who either have pre-existing
